Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
Federal Circuit Affirms Biosimilar Infringement Finding Against Mylan
cafc · 2025-03-14 · Plaintiff Win · Impact: 60/100
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., decided by Federal Circuit on March 14, 2025, resulted in a plaintiff win outcome. The core dispute centered on whether Mylan's proposed ...